Which strategy should be used for acute ST-elevation myocardial infarction in patients aged more than 75 years?

Area of Science:

• Cardiology
• Geriatric Medicine
• Interventional Cardiology

Background:

• Elderly patients (>or= 75 years) are under-represented in acute myocardial infarction (AMI) trials, leading to controversial optimal management strategies.
• Thrombolytic therapy is effective in reducing AMI mortality in the elderly, but less so than primary percutaneous coronary intervention (PCI).

Purpose of the Study:

• To review the current evidence on the optimal management of AMI in elderly patients.
• To compare the efficacy and safety of different reperfusion strategies in this population.

Main Methods:

• Review of randomized clinical trials comparing thrombolytic therapy, primary PCI, and mechanical interventions (stenting vs. balloon angioplasty).
• Evaluation of safety data, particularly regarding bleeding risks with adjunctive antithrombotic therapies.

Main Results:

• Primary PCI demonstrates superior outcomes compared to thrombolytic therapy for AMI in the elderly.
• Stenting is more effective than balloon angioplasty; the role of drug-eluting stents requires further investigation.
• Combination therapies with low molecular weight heparin or IIb/IIIa inhibitors and thrombolytics increase intracranial hemorrhage risk.

Conclusions:

• Primary PCI is preferred over thrombolytic therapy for AMI in the elderly when available.
• Further randomized trials are essential to define optimal reperfusion strategies, especially for patients without PCI facilities or with cardiogenic shock.